Daewoong's SGLT-2 Inhibitor Set For First Filing After Phase III

First Korean Contender In Class

 
• By Jung Won Shin
  
diabetes
Daewoong Speeds Up Novel Drug Development • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia